421 related articles for article (PubMed ID: 23020635)
1. Synthesis of 1-acetyl-3-(2-thienyl)-5-aryl-2-pyrazoline derivatives and evaluation of their anticancer activity.
Özdemir A; Altıntop MD; Kaplancıklı ZA; Turan-Zitouni G; Ciftçi GA; Yıldırım SU
J Enzyme Inhib Med Chem; 2013 Dec; 28(6):1221-7. PubMed ID: 23020635
[TBL] [Abstract][Full Text] [Related]
2. Pyrazoline analogs as potential anticancer agents and their apoptosis, molecular docking, MD simulation, DNA binding and antioxidant studies.
Rana M; Arif R; Khan FI; Maurya V; Singh R; Faizan MI; Yasmeen S; Dar SH; Alam R; Sahu A; Ahmad T; Rahisuddin
Bioorg Chem; 2021 Mar; 108():104665. PubMed ID: 33571809
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of novel analogs of 2-pyrazoline obtained from [(7-chloroquinolin-4-yl)amino]chalcones and hydrazine as potential antitumor and antimalarial agents.
Insuasty B; Montoya A; Becerra D; Quiroga J; Abonia R; Robledo S; Vélez ID; Upegui Y; Nogueras M; Cobo J
Eur J Med Chem; 2013 Sep; 67():252-62. PubMed ID: 23871905
[TBL] [Abstract][Full Text] [Related]
4. Design and stereoselective synthesis of novel isosteviol-fused pyrazolines and pyrazoles as potential anticancer agents.
Zhu SL; Wu Y; Liu CJ; Wei CY; Tao JC; Liu HM
Eur J Med Chem; 2013 Jul; 65():70-82. PubMed ID: 23693151
[TBL] [Abstract][Full Text] [Related]
5. New imidazo[1,2-b]pyrazoles as anticancer agents: synthesis, biological evaluation and structure activity relationship analysis.
Grosse S; Mathieu V; Pillard C; Massip S; Marchivie M; Jarry C; Bernard P; Kiss R; Guillaumet G
Eur J Med Chem; 2014 Sep; 84():718-30. PubMed ID: 25064349
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, structure, and in vitro antitumor activity of some glycoside derivatives of ferrocenyl-chalcones and ferrocenyl-pyrazolines.
Zsoldos-Mády V; Csámpai A; Szabó R; Mészáros-Alapi E; Pásztor J; Hudecz F; Sohár P
ChemMedChem; 2006 Oct; 1(10):1119-25. PubMed ID: 16944543
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and Evaluation of New Pyrazoline Derivatives as Potential Anticancer Agents.
Karabacak M; Altıntop MD; İbrahim Çiftçi H; Koga R; Otsuka M; Fujita M; Özdemir A
Molecules; 2015 Oct; 20(10):19066-84. PubMed ID: 26492233
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and cytotoxic activity of some novel steroidal C-17 pyrazolinyl derivatives.
Fan NJ; Tang JJ; Li H; Li XJ; Luo B; Gao JM
Eur J Med Chem; 2013 Nov; 69():182-90. PubMed ID: 24021891
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of 1-substituted 3-aryl-5-aryl(hetaryl)-2-pyrazolines and study of their antitumor activity.
Insuasty B; Chamizo L; Muñoz J; Tigreros A; Quiroga J; Abonía R; Nogueras M; Cobo J
Arch Pharm (Weinheim); 2012 Apr; 345(4):275-86. PubMed ID: 22105771
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, molecular docking and evaluation of thiazolyl-pyrazoline derivatives as EGFR TK inhibitors and potential anticancer agents.
Lv PC; Li DD; Li QS; Lu X; Xiao ZP; Zhu HL
Bioorg Med Chem Lett; 2011 Sep; 21(18):5374-7. PubMed ID: 21802290
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of novel thiazolone-based compounds containing pyrazoline moiety and evaluation of their anticancer activity.
Havrylyuk D; Zimenkovsky B; Vasylenko O; Zaprutko L; Gzella A; Lesyk R
Eur J Med Chem; 2009 Apr; 44(4):1396-404. PubMed ID: 19000643
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, antitumor, cytotoxic and antioxidant evaluation of some new pyrazolotriazines attached to antipyrine moiety.
Metwally MA; Gouda MA; Harmal AN; Khalil AM
Eur J Med Chem; 2012 Oct; 56():254-62. PubMed ID: 23022735
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, characterization and cytotoxicity of the gold(III) complexes of 4,5-dihydropyrazole-1-carbothioamide derivatives.
Wang S; Shao W; Li H; Liu C; Wang K; Zhang J
Eur J Med Chem; 2011 May; 46(5):1914-8. PubMed ID: 21392862
[TBL] [Abstract][Full Text] [Related]
14. Microwave-assisted synthesis, crystal structure of pyrazolo[1,5-a]pyrazin-4(5H)-ones and their selective effects on lung cancer cells.
Liu N; Zhang JH; Zhao BX; Zhao J; Su L; Dong WL; Zhang SL; Miao JY
Eur J Med Chem; 2011 Jun; 46(6):2359-67. PubMed ID: 21463913
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of novel 3,5-diaryl pyrazole derivatives using combinatorial chemistry as inhibitors of tyrosinase as well as potent anticancer, anti-inflammatory agents.
Bandgar BP; Totre JV; Gawande SS; Khobragade CN; Warangkar SC; Kadam PD
Bioorg Med Chem; 2010 Aug; 18(16):6149-55. PubMed ID: 20638287
[TBL] [Abstract][Full Text] [Related]
16. A novel methodology for synthesis of dihydropyrazole derivatives as potential anticancer agents.
Wang X; Pan YM; Huang XC; Mao ZY; Wang HS
Org Biomol Chem; 2014 Apr; 12(13):2028-32. PubMed ID: 24519368
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of novel tetrahydro-2H-Pyrano[3,2-c]pyridazin-3(6H)-one derivatives as potential anticancer agents.
Al-Tel TH
Eur J Med Chem; 2010 Dec; 45(12):5724-31. PubMed ID: 20884086
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, crystal structure and biological evaluation of novel 2-(5-(hydroxymethyl)-3-phenyl-1H-pyrazol-1-yl)-1-phenylethanol derivatives.
Zheng LW; Zhu J; Zhao BX; Huang YH; Ding J; Miao JY
Eur J Med Chem; 2010 Dec; 45(12):5792-9. PubMed ID: 20947221
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of a new series of thiazolyl-pyrazolines as dual EGFR and HER2 inhibitors.
Sever B; Altıntop MD; Radwan MO; Özdemir A; Otsuka M; Fujita M; Ciftci HI
Eur J Med Chem; 2019 Nov; 182():111648. PubMed ID: 31493743
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and anticancer activity of acyl thioureas bearing pyrazole moiety.
Koca İ; Özgür A; Coşkun KA; Tutar Y
Bioorg Med Chem; 2013 Jul; 21(13):3859-65. PubMed ID: 23664495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
